Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
Abbvie (ABBV) PT Raised to $145 at Argus
-
Notable Analyst Rating Changes 3/15: (DLPH) (WHR) (RCII) Upgraded; (DDD) (SAFM) (WLL) Downgraded
-
Pre-Open Stock Movers 03/05: (KYTH) (PCYC) (KR) Higher; (BRLI) (JOY) (ABBV) Lower (more...)
-
Notable Analyst Rating Changes 08/12: (FFIV) (CVC) (LKQ) Upgraded; (TSLA) (VOYA) (JNPR) Downgraded
-
Argus Starts Abbvie (ABBV) at Buy
-
Notable Analyst Rating Changes 01/16: (NFX) (PLXT) (DDR) Upgraded; (YELP) (AAPL) (IRWD) Downgraded
-
Notable Analyst Rating Changes 01/04: (JNJ) (ZQK) (AVP) Upgraded; (LULU) (MSFT) (ABT) Downgraded

